SCHEMBL334505

SCHEMBL334505

[c]1cn2cncc2s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5559610 0.51
SCHEMBL976327 0.50
Pyrazine SCHEMBL1226089 0.26 TSHR (0.50)
SCHEMBL8512657 0.26 HSP90AA1 (0.36)
Pyrazine SCHEMBL5179 0.26
Methane SCHEMBL23044967 0.21
SCHEMBL8636316 0.21
SCHEMBL6559802 0.21
SCHEMBL2968919 0.21
SCHEMBL1532368 0.21

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7871982-B2 Lincomycin derivatives and antimicrobial agents comprising the same as active ingredient MEIJI SEIKA KAISHA, LTD. (JP) 2011-01-18 US claimed
US-20090156512-A1 potent activity against resistant pneumococci MEIJI SEIKA KAISHA, LTD. (JP) 2009-06-18 US claimed
EP-1970377-A1 LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT MEIJI SEIKA KAISHA LTD. (JP) 2008-09-17 EP claimed
US-20070167423-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS GLAXO GROUP LIMITED 2007-07-19 US claimed
EP-0774466-A1 NOVEL CEPHEM DERIVATIVES MEIJI SEIKA KABUSHIKI KAISHA (JP) 1997-05-21 EP claimed
US-20240174710-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS WAVE LIFE SCIENCES LTD. (SG) 2024-05-30 US disclosed
US-20240051966-A1 CD16A BINDING AGENTS AND USES THEREOF KLEO PHARMACEUTICALS, INC. 2024-02-15 US disclosed
US-11873316-B2 Compositions and methods for phosphoramidite and oligonucleotide synthesis WAVE LIFE SCIENCES LTD. (SG) 2024-01-16 US disclosed
US-11834482-B2 Agents modulating beta-catenin functions and methods thereof FOG PHARMACEUTICALS, INC. (US) 2023-12-05 US disclosed
US-20230348524-A1 TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION WAVE LIFE SCIENCES LTD. (SG) 2023-11-02 US disclosed
US-11739325-B2 Oligonucleotide compositions and methods thereof WAVE LIFE SCIENCES LTD. (SG) 2023-08-29 US disclosed
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed
WO-2006133946-A1 AZAB I CYCLO [3 . 1 . 0] HEXANE DERIVATIVES AS DOPAMIN D3 RECEPTOR MODULATORS GLAXO GROUP LIMITED (GB) 2006-12-21 WO disclosed
US-20060229312-A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors GLAXO GROUP LIMITED (GB) 2006-10-12 US disclosed
WO-2006002928-A1 COMPOUNDS HAVING AFFINITY FOR THE DOPAMINE D3 RECEPTOR AND USES THEREOF IN MEDICINE GLAXO GROUP LIMITED (GB) 2006-01-12 WO disclosed
WO-2005040095-A1 INHIBITORS OF DIPEPTIDYL PEPTIDASE IV ASTRAZENECA AB (SE) 2005-05-06 WO disclosed
WO-2001053305-A1 PROCESSES FOR THE PREPARATION OF CARBAPENEM DERIVATIVES MEIJI SEIKA KAISHA, LTD. (JP) 2001-07-26 WO disclosed
EP-0774466-A4 NOVEL CEPHEM DERIVATIVES MEIJI SEIKA CO (JP) 1998-09-02 EP disclosed
EP-0774466-A1 NOVEL CEPHEM DERIVATIVES MEIJI SEIKA KABUSHIKI KAISHA (JP) 1997-05-21 EP disclosed
WO-1996037499-A1 NOVEL CEPHEM DERIVATIVES MEIJI SEIKA KABUSHIKI KAISHA (JP) 1996-11-28 WO disclosed